Camptodactyly syndrome, Guadalajara type 3
Camptodactyly syndrome Guadalajara type 3 is a rare genetic bone development disorder characterized by hand camptodactyly associated with facial dysmorphism (flat face hypertelorism telecanthus symblepharon simplified ears retrognathia) and neck anomalies (short neck with stricking pterygia muscle sclerosis). Additional features include spinal defects (e.g. cervical and dorso-lumbar spina bifida occulta) congenital shortness of the sternocleidomastoid muscle flexed wrists and thin hands and feet. Brain structural anomalies multiple nevi micropenis and mild intellectual disability are also observed. Imaging reveals increased bone traveculae cortical thickening of long bones and delayed bone age.
Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.
Reference: Access aggregated data from Orphanet at Orphadata.
Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http: //www.orphadata.org. Data version September 2023.
Newly diagnosed with
Camptodactyly syndrome, Guadalajara type 3?
Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.
Advocacy Organizations
DDX3X Foundation
Our mission is to connect families, resources, and the medical community to advance research for a treatment or cure to DDX3X Syndrome. Our ultimate goal is to accelerate brain function in individuals affected by DDX3X Syndrome through advances in cell and gene therapy and pharmaceuticals.
Syndromes Without A Name (SWAN) Australia
Provide information, support and advocacy to families caring for a child with an undiagnosed or rare genetic condition.
Moonshots for Unicorns
Curing single-gene disorders
COMBINEDBrain Inc
COMBINEDBrain is a consortium for outcome measures and biomarkers for neurodevelopmental disorders. We are collaborating to cure rare, non-verbal brain disorders.
Clinical Trials
For a list of clinical trials in this disease area, please click here.